Verbatim response from Claude
Wegovy vs Zepbound: Quick Comparison
The Drugs
Wegovy (semaglutide)
- GLP-1 receptor agonist
- Average weight loss: ~15% body weight
- Made by Novo Nordisk
- Longer track record/more data
Zepbound (tirzepatide)
- Dual GLP-1/GIP receptor agonist
- Average weight loss: ~20-22% body weight
- Made by Eli Lilly
- Slightly newer but strong clinical data
→ If maximum weight loss is the goal, Zepbound currently shows an edge in studies
Where to Get Either Online
Reputable telehealth providers:
- Hims & Hers – offers both, competitive pricing
- Ro (Body program) – well-established, good support
- WeightWatchers Clinic – combines medication + coaching
- Noom Med – pairs medication with behavioral support
- Found – good for insurance navigation help
Important Caveats
- ⚠️ You need a prescription from a licensed provider
- Insurance coverage varies significantly and affects cost dramatically
- A real clinician should make the final call based on your health history
- Avoid any site that skips a medical consultation
Would you like more detail on cost or insurance tips?